Shared decision making in high-grade glioma patients-a systematic review

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

DOI

  • Helle Sorensen von Essen, Department of Neurosurgery, Odense University Hospital, Odense., Department of Clinical Research and BRIDGE (Brain Research-Interdisciplinary Guided Excellence), University of Southern Denmark, Danmark
  • Karin Piil
  • Karina Dahl Steffensen, Lillebaelt Hospital – University Hospital of Southern Denmark, Center for Shared Decision Making, Region of Southern Denmark, Vejle, Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, 5230 Odense, Denmark., Danmark
  • Frantz Rom Poulsen, Department of Neurosurgery, Odense University Hospital, Odense., Department of Clinical Research and BRIDGE (Brain Research-Interdisciplinary Guided Excellence), University of Southern Denmark, Danmark

Background: Shared decision making (SDM) has proven to be a valuable approach in different patient populations when treatment decisions are called for. Along the disease trajectory of high-grade glioma (HGG), patients are presented with a series of treatment decisions. At the same time, HGG patients often experience cognitive deterioration and reduced decision-making capacity. This study aimed to review the current knowledge about shared decision making from the perspective of the HGG patient.

Methods: Systematic searches were performed in MEDLINE, CINAHL, PsycINFO, and EMBASE. Studies were reviewed against the inclusion criteria and assessed for methodological quality. Descriptive data from the included studies were extracted and a narrative synthesis of the findings was performed.

Results: The searches resulted in 5051 original records. Four studies involving 178 HGG patients fulfilled the inclusion criteria. The narrative synthesis revealed that most HGG patients in the included studies appreciated an SDM approach and that sufficient information and involvement increased patients' emotional well-being. The use of a patient decision aid showed the potential to increase knowledge, decrease uncertainty, and affect the treatment decision making of HGG patients.

Conclusion: The results indicate that many HGG patients prefer an SDM approach and that SDM can lead patients toward improved emotional well-being. The evidence is weak, however, and firm conclusions and practice guidelines concerning SDM in HGG patients cannot be made. Future research is warranted to improve decision support for HGG patients.

OriginalsprogEngelsk
TidsskriftNeuro-oncology practice
Vol/bind7
Nummer6
Sider (fra-til)589-598
Antal sider10
ISSN2054-2577
DOI
StatusUdgivet - dec. 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 207044739